Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mature T-cell Lymphoma”

1,081 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,081 results

Early research (Phase 1)Study completedNCT00470405
What this trial is testing

Pemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or Lymphoma

Who this might be right for
LymphomaSolid Tumor
Vanderbilt-Ingram Cancer Center 25
Not applicableUnknownNCT03268889
What this trial is testing

Chidamide With CHOP Regimen for de Novo PTCL Patients (CHOP: Cyclophosphamide, Etoposide, Vincristine and Prednisone; PTCL: Peripheral T Cell Lymphoma)

Who this might be right for
Peripheral T Cell Lymphoma
The First Affiliated Hospital of Soochow University 39
Large-scale testing (Phase 3)Study completedNCT00005590
What this trial is testing

Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerExtragonadal Germ Cell Tumor+7 more
Cancer Research Campaign Clinical Trials Centre
Early research (Phase 1)Study completedNCT00006340
What this trial is testing

Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus

Who this might be right for
LeukemiaLymphomaPrecancerous Condition+1 more
Boston Medical Center
Early research (Phase 1)UnknownNCT00562068
What this trial is testing

Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell Lymphoma

Who this might be right for
LymphomaSmall Intestine Cancer
Cancer Research UK 30
Large-scale testing (Phase 3)Looking for participantsNCT06561048
What this trial is testing

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

Who this might be right for
Peripheral T-Cell Lymphoma, Not Otherwise SpecifiedAngioimmunoblastic T-cell LymphomaFollicular T-Cell Lymphoma+4 more
Corvus Pharmaceuticals, Inc. 150
Very early researchEnded earlyNCT01878708
What this trial is testing

A Pilot Study of Oncaspar® + Dexamethasone in Patients With Relapsed or Refractory T-Cell Lymphoma

Who this might be right for
T-Cell LymphomaRelapsed T-Cell LymphomaRefractory T-Cell Lymphoma
Dana-Farber Cancer Institute 2
Post-approval studies (Phase 4)UnknownNCT04040491
What this trial is testing

PD-1 Antibody, Chidamide, Lenalidomide and Gemcitabine for Peripheral T-cell Lymphoma

Who this might be right for
Peripheral T-cell Lymphoma
Mingzhi Zhang 100
Not applicableStudy completedNCT06113081
What this trial is testing

Real World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma

Who this might be right for
Cutaneous T Cell LymphomaCutaneous T-Cell Lymphoma/Mycosis FungoidesCutaneous T-Cell Lymphoma/Sezary Syndrome
Fondazione Italiana Linfomi - ETS 100
Early research (Phase 1)WithdrawnNCT00458744
What this trial is testing

Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment

Who this might be right for
Brain and Central Nervous System TumorsLeukemiaLymphoma+1 more
Children's Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00002635
What this trial is testing

Aminocamptothecin in Treating Patients With T-cell Lymphoma

Who this might be right for
Lymphoma
Yale University 12
Early research (Phase 1)Active Not RecruitingNCT04526834
What this trial is testing

Phase 1 Study of Autologous CD30.CAR-T in Relapsed or Refractory CD30 Positive Non-Hodgkin Lymphoma

Who this might be right for
Anaplastic Large Cell LymphomaPeripheral T Cell LymphomaExtranodal NK/T-cell Lymphoma+2 more
Tessa Therapeutics 21
Early research (Phase 1)Study completedNCT00003993
What this trial is testing

Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
National Institute on Aging (NIA) 24
Testing effectiveness (Phase 2)Ended earlyNCT03947255
What this trial is testing

Retreatment With Brentuximab Vedotin in Subjects With Classic Hodgkin Lymphoma or CD30-expressing Peripheral T Cell Lymphoma

Who this might be right for
Hodgkin LymphomaPeripheral T Cell LymphomaAnaplastic Large Cell Lymphoma
Seagen Inc. 12
Early research (Phase 1)Study completedNCT01804335
What this trial is testing

CD5789 in Early Cutaneous T-Cell Lymphoma (CTCL)

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT00005040
What this trial is testing

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06855823
What this trial is testing

A Phase I/II Study of Golidocitinib Combined with Pomalidomide in R/R PTCL

Who this might be right for
Relapsed/Refractory Peripheral T-Cell Lymphoma (R/R PTCL)
Sun Yat-sen University 33
Not applicableStudy completedNCT06149390
What this trial is testing

ASCT Versus Chemotherapy as First-Line Consolidation Therapy inT-Cell Lymphoma

Who this might be right for
T-cell Lymphoma Adults
Huazhong University of Science and Technology 347
Not applicableStudy completedNCT00002520
What this trial is testing

Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Eastern Cooperative Oncology Group 434
Early research (Phase 1)Ended earlyNCT00996359
What this trial is testing

Partially HLA-Matched Irradiated Allogeneic Cellular Therapy After Reduced Intensity Total Body Irradiation

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of Medicine and Dentistry of New Jersey 4
Load More Results